WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹3.95 Cr | ₹3.44 Cr | ₹0.21 Cr | ₹3.59 Cr | ₹2.88 Cr |
What is the latest Total Non-Current Liabilities ratio of WINDLAS BIOTECH ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹3.95 Cr |
Mar2023 | ₹3.44 Cr |
Mar2022 | ₹0.21 Cr |
Mar2021 | ₹3.59 Cr |
Mar2020 | ₹2.88 Cr |
How is Total Non-Current Liabilities of WINDLAS BIOTECH Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹3.95 Cr | 14.84 | |
Mar2023 | ₹3.44 Cr | 1,513.62 | |
Mar2022 | ₹0.21 Cr | -94.06 | |
Mar2021 | ₹3.59 Cr | 24.61 | |
Mar2020 | ₹2.88 Cr | - |
Compare Total Non-Current Liabilities of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹2,057.1 Cr | -0.9% | -5.9% | 76.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹440,314.0 Cr | -0.4% | 5.7% | 20.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,809.0 Cr | 1.7% | 6.2% | 52.9% | Stock Analytics | |
CIPLA | ₹124,627.0 Cr | -0.7% | 7% | 8.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,127.0 Cr | -1.6% | 1.5% | 21.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,839.9 Cr | -2.3% | 2.5% | -6% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | -0.9% |
-5.9% |
76.5% |
SENSEX | 2% |
4.1% |
9.6% |
You may also like the below Video Courses